Skip Nav Destination
Issues
February 2022
ISSN 0954-982X
EISSN 1740-1194
In this Issue
Bioenterprise
Editorial
Feature
Government science ambitions require greater funding and wider public understanding
Biochem (Lond) (2022) 44 (1): 2–5.
Opening new doors to new bio-businesses and their novel products and processes
Biochem (Lond) (2022) 44 (1): 11–19.
Beginner’s Guide
Interview
NovaBiotics’ journey to commercialization of novel immune-based therapies
Biochem (Lond) (2022) 44 (1): 25–26.
